Browsing: Novo Nordisk
Investor optimism about the pill version of weight-loss injectables being developed by Sam Chun Dang Pharm (SCD) in South Korea…
ToplineShares of Novo Nordisk slumped to their lowest level since July 2021 on Monday morning after the drugmaker announced that…
South Korea’s biotech sector is having its moment. Investor optimism about the pipeline of cancer drugs being developed by biotech…
A $2.6 billion licensing and joint research deal with Eli Lilly boosted shares of South Korean biotech company ABL Bio…